BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Identification of troglitazone responsive genes: induction of RTP801 during troglitazone-induced apoptosis in Hep 3B cells

  • Kim, Jin-Oh (Department of Immunology, School of Medicine, Kyungpook National University) ;
  • Kim, Ji-Young (Department of Biochemistry, Kyungpook National University) ;
  • Kwack, Mi-Hee (Department of Immunology, School of Medicine, Kyungpook National University) ;
  • Hong, Su-Hyung (Dental Microbiology, School of Dentistry, Kyungpook National University) ;
  • Kim, Moon-Kyu (Department of Immunology, School of Medicine, Kyungpook National University) ;
  • Kim, Jung-Chul (Department of Immunology, School of Medicine, Kyungpook National University) ;
  • Sung, Young-Kwan (Department of Immunology, School of Medicine, Kyungpook National University)
  • Received : 2010.05.24
  • Accepted : 2010.07.26
  • Published : 2010.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Troglitazone is an anti-diabetic agent that improves hyperglycemia by reducing peripheral insulin resistance in type II diabetic patients. Troglitazone has been shown to cause growth inhibition of various normal and cancerous cells. However, the molecular mechanism by which troglitazone affects the growth of these cancer cells remains unclear. Here, we report that troglitazone treatment of Hep 3B human hepatocellular carcinoma cells resulted in dose-dependent growth inhibition. Analysis of cell cycle distribution by flow cytometry showed that the number of apoptotic cells was increased in a dose-dependent manner in response to troglitazone treatment. cDNA microarray analysis showed a number of differentially expressed genes in response to troglitazone. Among the upregulated genes, hypoxia-inducible factor 1 (HIF-1)-responsive RTP801 was induced in a dose-dependent manner. We also observed HIF-1 accumulation by immnocytochemistry after troglitazone treatment. These results strongly suggest that RTP801 might be involved in troglitazone-induced apoptosis in Hep 3B cells.

Keywords

References

  1. Koga, H., Sakisaka, S., Harada, M., Takagi, T., Hanada, S., Taniguchi, E., Kawaguchi, T., Sasatomi, K., Kimura, R., Hashimoto, O., Ueno, T., Yano, H., Kojiro, M. and Sata, M. (2001) Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Hepatology 33, 1087-1097. https://doi.org/10.1053/jhep.2001.24024
  2. Yoshizawa, K., Cioca, D. P., Kawa, S., Tanaka, E. and Kiyosawa, K. (2002) Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines. Cancer 95, 2243-2251. https://doi.org/10.1002/cncr.10906
  3. Bae, M. A., Rhee, H. and Song, B. J. (2003) Troglitazone but not rosiglitazone induces G1 cell cycle arrest and apoptosis in human and rat hepatoma cell lines. Toxicol. Lett. 139, 67-75. https://doi.org/10.1016/S0378-4274(02)00468-X
  4. Weng, J. R., Chen, C. Y., Pinzone, J. J., Ringel, M. D. and Chen, C. S. (2006) Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones. Endocr. Relat. Cancer 13, 401-413. https://doi.org/10.1677/erc.1.01182
  5. Shoshani, T., Faerman, A., Mett, I., Zelin, E., Tenne, T., Gorodin, S., Moshel, Y., Elbaz, S., Budanov, A., Chajut, A., Kalinski, H., Kamer, I., Rozen, A., Mor, O., Keshet, E., Leshkowitz, D., Einat, P., Skaliter, R. and Feinstein, E. (2002) Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol. Cell Biol. 22, 2283-2293. https://doi.org/10.1128/MCB.22.7.2283-2293.2002
  6. Kim, J. R., Lee, S. R., Chung, H. J., Kim, S., Baek, S. H., Kim, J. H. and Kim, Y. S. (2003) Identification of amyloid beta-peptide responsive genes by cDNA microarray technology: involvement of RTP801 in amyloid beta-peptide toxicity. Exp. Mol. Med. 35, 403-411. https://doi.org/10.1038/emm.2003.53
  7. Schwarzer, R., Tondera, D., Arnold, W., Giese, K., Klippel, A. and Kaufmann, J. (2005) REDD1 integrates hypoxia- mediated survival signaling downstream of phosphatidylinositol 3-kinase. Oncogene 24, 1138-1149. https://doi.org/10.1038/sj.onc.1208236
  8. Yu, J., Qiao, L., Zimmermann, L., Ebert, M. P., Zhang, H., Lin, W., Rocken, C., Malfertheiner, P. and Farrell, G. C. (2006) Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo. Hepatology 43, 134-143. https://doi.org/10.1002/hep.20994
  9. Park, B. C., Thapa, D., Lee, J. S., Park, S. Y. and Kim, J. A. (2009) Troglitazone inhibits vascular endothelial growth factor-induced angiogenic signaling via suppression of reactive oxygen species production and extracellular signal-regulated kinase phosphorylation in endothelial cells. J. Pharmacol. Sci. 111, 1-12. https://doi.org/10.1254/jphs.08305FP
  10. Carroll, C. W. and Morgan, D. O. (2002) The Doc1 subunit is a processivity factor for the anaphase-promoting complex. Nat. Cell Biol. 4, 880-887. https://doi.org/10.1038/ncb871
  11. Ma, S., Liu, M. A., Yuan, Y. L. and Erikson, R. L. (2003) The serum-inducible protein kinase Snk is a G1 phase polo-like kinase that is inhibited by the calcium- and integrin-binding protein CIB. Mol. Cancer Res. 1, 376-384.
  12. Ellisen, L. W., Ramsayer, K. D., Johannessen, C. M., Yang, A., Beppu, H., Minda, K., Oliner, J. D., McKeon, F. and Haber, D. A. (2002) REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol. Cell 10, 995-1005. https://doi.org/10.1016/S1097-2765(02)00706-2
  13. Narayanan, P. K., Hart, T., Elcock, F., Zhang, C., Hahn, L., McFarland, D., Schwartz, L., Morgan, D. G. and Bugelski, P. (2003) Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: a flow cytometric assessment. Cytometry A. 52, 28-35.
  14. Sung, Y. K., Hwang, S. Y., Farooq, M., Kim, J. C. and Kim, M. K. (2003) Growth promotion of HepG2 hepatoma cells by antisense-mediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling. Exp. Mol. Med. 35, 257-262. https://doi.org/10.1038/emm.2003.34
  15. Farooq, M., Hwang, S. Y., Park, M. K., Kim, J. C., Kim, M. K. and Sung, Y. K. (2003) Blocking endogenous glypican-3 expression releases Hep 3B cells from G1 arrest. Mol. Cells 15, 356-360.
  16. Chung, E. J., Sung, Y. K., Farooq, M., Kim, Y., Im, S., Tak, W. Y. ,Hwang, Y. J., Kim, Y. I., Han, H. S., Kim, J. C. and Kim, M. K. (2002) Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray. Mol. Cells 14, 382-387.
  17. Shin, H., Kwack, M. H., Shin, S. H., Oh, J. W., Kang, B. M., Kim, A. A., Kim, J., Kim, M. K., Kim, J. C. and Sung, Y. K. (2010) Identification of transcriptional targets of Wnt/beta-catenin signaling in dermal papilla cells of human scalp hair follicles: EP2 is a novel transcriptional target of Wnt3a. J. Dermatol. Sci. 58, 91-96. https://doi.org/10.1016/j.jdermsci.2010.02.011

Cited by

  1. DNA Damage-Inducible Transcript 4 Is an Innate Surveillant of Hair Follicular Stress in Vitamin D Receptor Knockout Mice and a Regulator of Wound Re-Epithelialization vol.17, pp.12, 2016, https://doi.org/10.3390/ijms17121984